Improve Research Reproducibility A Bio-protocol resource
Concise Method
tooltip

Eligibility and exclusion criteria

HC Hee-young Choi
SK Su-Jin Kim
SK Sang Yoon Kim
JL Ji-Eun Lee
request Request a Protocol
ask Ask a question
Favorite

The major eligibility criteria of the HH group included age between 20 and 80 years (at the time of enrollment), HH resulting from brain lesions, and BCVA of 20/30 or better in each eye. Exclusion criteria were: an ocular etiology for reduced vision, myopia worse than − 6.0 diopters (D) spherical equivalent in any eye, prior intraocular or refractive surgery, diagnosis of glaucoma, and intellectual deficit.

The eligibility criteria of the monocular blindness group were: absence of a history of VFDs and BCVA 20/800 or less in the worse eye. Exclusion criteria were: an ocular co-morbidity that may reduce VA, ocular disease that my reduce visual field, intraocular injury, prior intraocular surgery in better eye, and cognitive delays that may impact testing.

Copyright and License information: The Author(s) ©2022
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A